Restatement of Previously Issued Financial Statements - Schedule of Consolidated Statements of Operations (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2025	Mar. 31, 2025	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2025	Jun. 30, 2024
Consolidated Statements of Operations
Revenues	$ 32,472		$ 39,783		$ 67,229	$ 72,904
Cost of revenues	24,359		28,720		51,728	54,855
Gross margin	8,113		11,063		15,501	18,049
Operating expenses:
Selling, general and administrative	21,487		23,364		44,219	40,312
Research and development	4,393		3,565		8,559	4,709
Restructuring Charges	1,899		457		3,597	1,317
Transaction expenses	0		347		0	1,450
Goodwill impairment	70,636	$ 0	0	$ 85,000	70,636	85,000
Operating loss	(90,302)		(16,670)		(111,510)	(114,739)
Interest expense	4,419		6,452		9,535	12,837
Net increase in fair value of derivatives	135,751		(8,081)		169,087	15,726
Other income	(1,867)		(617)		(2,143)	(1,072)
Loss before taxes	(228,605)		(14,424)		(290,566)	(142,230)
Income tax benefit	14		15		39	1
Net loss	$ (228,619)		(14,439)		$ (290,605)	(142,231)
As reported
Consolidated Statements of Operations
Revenues			39,783			72,904
Cost of revenues			28,720			54,855
Gross margin			11,063			18,049
Operating expenses:
Selling, general and administrative			23,364			40,312
Research and development			3,565			4,709
Restructuring Charges			457			1,317
Transaction expenses			347			1,450
Goodwill impairment			0			85,000
Operating loss			(16,670)			(114,739)
Interest expense			3,551			7,106
Net increase in fair value of derivatives			(7,882)			16,110
Other income			(617)			(1,072)
Loss before taxes			(11,722)			(136,883)
Income tax benefit			15			1
Net loss			(11,737)			(136,884)
Adjustment
Consolidated Statements of Operations
Revenues			0			0
Cost of revenues			0			0
Gross margin			0			0
Operating expenses:
Selling, general and administrative			0			0
Research and development			0			0
Restructuring Charges			0			0
Transaction expenses			0			0
Goodwill impairment			0			0
Operating loss			0			0
Interest expense			2,901			5,731
Net increase in fair value of derivatives			(199)			(384)
Other income			0			0
Loss before taxes			(2,702)			(5,347)
Income tax benefit			0			0
Net loss			$ (2,702)			$ (5,347)